The document discusses the potential medical applications of fisheries byproducts. It outlines several examples, including using sn-2 docosahexaenoic acid inserted phospholipids from fish oils to enhance tumor survival and promote cancer cell differentiation. Additionally, it proposes using squid pen chitin laminated with salmon skin collagen as an artificial human skin and developing salmon testis DNA-alginic acid films that can be impregnated with silver ions. Finally, the document notes that a novel peptidoglycan from squid ink was found to have antitumor activity, demonstrating the potential for new medicines from fisheries byproducts.